START and AHN Partner to Expand Early-Phase Cancer Trials in Western Pennsylvania — The START Center for Cancer Research

Event summary

The START Center for Cancer Research and Allegheny Health Network (AHN) will establish a new START early-phase clinical trial site within AHN’s Cancer Center at Allegheny General Hospital.
The collaboration aims to expand access to novel investigational cancer therapies for patients across western Pennsylvania, addressing a significant need in the region.
START’s expertise in early-phase oncology trials will be integrated with AHN’s network of cancer specialists, reducing barriers to trial participation.
AHN serves over 20,000 new cancer patients annually, with the new site providing immediate access to START’s global trial portfolio of nearly 1,000 active studies.

The big picture

The collaboration aligns with the broader trend of bringing clinical research closer to patient care settings, reducing barriers to participation in early-phase trials. With western Pennsylvania seeing approximately 89,000 new cancer cases annually, this partnership could set a precedent for similar integrations in other underserved regions. The move also underscores the growing importance of community-based oncology research in accelerating the development of novel cancer therapies.

What we're watching

Execution Risk: The pace at which the new site integrates into AHN’s existing cancer care infrastructure and START’s trial portfolio will determine its success.
Market Penetration: Whether the collaboration can significantly reduce the need for patients to travel outside the region for early-phase trials.
Regulatory Dynamics: How the partnership navigates regulatory requirements for clinical trials, ensuring compliance while maintaining operational efficiency.